Biohaven Therapeutics Ltd. clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.

1. Minor

   RISE 2 · If BHV-7000 is Effective and Safe · Refractory Focal…RISE 2 · If BHV-7000 is Effective and Safe · Refractory Focal Onset Epilepsy

   Enrollment closed, study ongoing

   Also in this update: Trial sites reduced: 124 → 104 locations

   Biohaven Therapeutics Ltd.·Phase 2/3· NCT06132893· Registry history of NCT06132893 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

2. Minor

   If BHV-1300 is Effective and Safe · Graves' Disease

   Trial sites expanded: 52 → 55 locations

   And 1 more change in the last 30 days

   Biohaven Therapeutics Ltd.·Phase 3· NCT07661056· Registry history of NCT07661056 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

3. Minor

   If BHV-8000 is Effective, Safe and Tolerable as a Treatment…If BHV-8000 is Effective, Safe and Tolerable as a Treatment · Early Parkinson's Disease

   Trial sites expanded: 19 → 22 locations

   Biohaven Therapeutics Ltd.·Phase 2/3· NCT06976268· Registry history of NCT06976268 on ClinicalTrials.gov (opens the registry)

   Updated Sep 17, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.